387187000: Zalcitabine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Reverse transcriptase inhibitor\Zalcitabine (substance)
\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Zalcitabine (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Zalcitabine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine nucleoside\Zalcitabine (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine nucleoside\Zalcitabine (substance)
\Organic compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine nucleoside\Zalcitabine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461365011 Zalcitabine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481294013 Zalcitabine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

850101000172116 zalcitabine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Zalcitabine (substance)	Is a	Reverse transcriptase inhibitor	true	Inferred relationship	Some
Zalcitabine (substance)	Is a	classe d'allergènes	false	Inferred relationship	Some
Zalcitabine (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some
Zalcitabine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Reverse transcriptase inhibitor (disposition)	true	Inferred relationship	Some
Zalcitabine (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Zalcitabine (substance)	Is a	Pyrimidine nucleoside	true	Inferred relationship	Some
Zalcitabine (substance)	Is a	Transferase inhibitor	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Zalcitabine adverse reaction	Causative agent (attribute)	True	Zalcitabine (substance)	Inferred relationship	Some	1
Allergy to zalcitabine	Causative agent (attribute)	False	Zalcitabine (substance)	Inferred relationship	Some
Zalcitabine 750 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zalcitabine (substance)	Inferred relationship	Some
Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zalcitabine (substance)	Inferred relationship	Some
Product containing zalcitabine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zalcitabine (substance)	Inferred relationship	Some	1
Allergy to zalcitabine	Causative agent (attribute)	True	Zalcitabine (substance)	Inferred relationship	Some	1
Allergy to zalcitabine	Causative agent (attribute)	False	Zalcitabine (substance)	Inferred relationship	Some	2
Zalcitabine 750 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zalcitabine (substance)	Inferred relationship	Some	1
Zalcitabine 750 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Zalcitabine (substance)	Inferred relationship	Some	1
Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zalcitabine (substance)	Inferred relationship	Some	1
Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Zalcitabine (substance)	Inferred relationship	Some	1
Zalcitabine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zalcitabine (substance)	Inferred relationship	Some	1
Zalcitabine 750 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Zalcitabine (substance)	Inferred relationship	Some	1
Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Zalcitabine (substance)	Inferred relationship	Some	1
Product containing only zalcitabine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zalcitabine (substance)	Inferred relationship	Some	1
Zalcitabine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zalcitabine (substance)	Inferred relationship	Some	1

This concept is not in any reference sets